With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...
Endothelial cells incubated in high glucose exhibited production of reactive nitrogen and oxygen species, consequent single-strand DNA breakage, PARP activation and associated metabolic and ...
Sodium is an electrolyte that helps regulate water levels and other bodily substances. Low sodium levels, or hyponatremia, can lead to lethargy, confusion, fatigue, and other symptoms. Treating ...
To view dis content choose 'accept and continue'. End of Twitter post Content is not available Wia dis foto come from, Getty Images Dis na di full list of products wey di 25% tariff go affect. and e ...
In this context, designing an adequate automatic glucose supply for TPBR is challenging. From the operator’s perspective, understanding and interpreting the response of such a complex system is ...
Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near
The sodium glucose co-transporter 2 (SGLT2) functions in the proximal tubule to reabsorb the bulk of filtered glucose. SGLT2 inhibitors have been developed to promote renal glucose excretion to ...
Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results